40
Participants
Start Date
August 31, 2002
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2004
Tesmac
Subjects were treated twice daily for five consecutive days, followed by two days untreated, and then treated twice daily for five more consecutive days.
Sham Tesmac device
Treatment with inactivated Tesmac device on the same schedule as the group treated with the active Tesmac device.
Lead Sponsor
Acuity Medical International, Inc.
INDUSTRY